Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
51M
-
Shares change
-
+920K
-
Total reported value, excl. options
-
$326M
-
Value change
-
+$3.63M
-
Put/Call ratio
-
0
-
Number of buys
-
87
-
Number of sells
-
-89
-
Price
-
$6.39
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q2 2024
200 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q2 2024.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51M shares
of 69.1M outstanding shares and own 73.77% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.43M shares), VANGUARD GROUP INC (4.53M shares), First Light Asset Management, LLC (3.96M shares), MILLENNIUM MANAGEMENT LLC (2.41M shares), PRIMECAP MANAGEMENT CO/CA/ (2.38M shares), Daventry Group, LP (2.25M shares), Bank of New York Mellon Corp (2.23M shares), Impax Asset Management Group plc (2.19M shares), WELLINGTON MANAGEMENT GROUP LLP (1.89M shares), and DIMENSIONAL FUND ADVISORS LP (1.4M shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.